Acutaas Chemicals Share Price Today | Stock Price & Acutaas Chemicals Share Screener
As of November 18, 2026, the live Acutaas Chemicals share price (NSE: ACUTAAS) is ₹3,991.30 on NSE and ₹3,995.60 on BSE, up 1.23% from the previous close, with shares trading between ₹3,934.20 and ₹4,017.60 in today's trading session, and a 52-week range of ₹1,602.50–₹4,039.10. Track ACUTAAS market capitalization to gauge the company's total market size. Use the Acutaas Chemicals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Acutaas Chemicals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹442 and net income of ₹123, with EBITDA of ₹181, an operating margin of 40.0% and a profit margin of 27.8%.
Acutaas Chemicals Share Price Chart
Track the current stock price of Acutaas Chemicals with an interactive chart. Analyse ACUTAAS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Acutaas Chemicals stock quote in one place.
The quote of ₹3,991.30 sits between the 52-week low of ₹1,602.50 and the 52-week high of ₹4,039.10, and the latest session moved 1.23% from the previous close.
Acutaas Chemicals Company Profile - Fundamental Screener
Screen Acutaas Chemicals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ACUTAAS shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE00FF01025.
Company Details
Classification
Identifiers and Leadership
Acutaas Chemicals Balance Sheet Screener
Screen ACUTAAS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹1,984, up from ₹1,549 in 2025.
Latest statistics put total assets at ₹1,984 and shareholder funds at ₹1,711, with a leverage ratio of 0.02.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
Assets |
||||||||
| Total Assets | 1,984 | 1,549 | 1,096 | 767 | 659 | 413 | 232 | 213 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 745 | 570 | 427 | 259 | 205 | 186 | 85 | 79 |
Liabilities |
||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 42 | 27 | 128 | 10 | 7 | 80 | 26 | 25 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||
| Total Equity | 1,711 | 1,320 | 683 | 594 | 522 | 167 | 112 | 82 |
| Share Capital | 41 | 41 | 37 | 36 | 36 | 32 | 11 | 11 |
| Reserves & Surplus | 1,613 | 1,269 | 637 | 558 | 486 | 135 | 101 | 72 |
Acutaas Chemicals Income Statement Screener - Profit & Revenue Analysis
Screen Acutaas Chemicals income statement and profit fundamentals. Analyze ACUTAAS quarterly results. Acutaas Chemicals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Sept, revenue was ₹442 and net profit was ₹123, equal to earnings per unit of ₹15.29, at an operating margin of 40%.
In that period expenses were ₹261, interest cost ₹1 and tax ₹44. The next period listed, 2026-Jun, shows revenue of ₹332 and net profit of ₹75.
| Item | 2026-Sept | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 442 | 332 | 444 | 398 | 316 | 223 | 314 | 277 | 255 | 178 | 226 | 170 | 174 | 155 | 186 |
| Expenses | 261 | 217 | 249 | 243 | 211 | 156 | 224 | 206 | 198 | 147 | 182 | 140 | 179 | 120 | 146 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 181 | 115 | 195 | 155 | 105 | 67 | 91 | 70 | 57 | 31 | 44 | 30 | -5 | 35 | 41 |
| Operating Profit % | 40.00% | 34.00% | 42.00% | 38.00% | 31.00% | 25.00% | 28.00% | 25.00% | 20.00% | 17.00% | 19.00% | 16.00% | -4.00% | 22.00% | 22.00% |
| Depreciation | 13 | 10 | 10 | 10 | 8 | 8 | 7 | 6 | 7 | 6 | 5 | 4 | 4 | 4 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 2 | 3 | 1 | 1 | 1 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 167 | 104 | 184 | 145 | 96 | 58 | 83 | 63 | 50 | 20 | 37 | 24 | -10 | 31 | 37 |
| Tax | 44 | 29 | 50 | 38 | 24 | 14 | 20 | 18 | 13 | 5 | 12 | 6 | 7 | 9 | 10 |
| Net Profit | 123 | 75 | 134 | 106 | 72 | 44 | 63 | 46 | 38 | 15 | 26 | 18 | -17 | 22 | 27 |
| EPS | 15.29 | 9.07 | 16.09 | 13.19 | 8.82 | 5.41 | 7.80 | 11.35 | 9.38 | 3.67 | 6.85 | 4.83 | -4.67 | 4.57 | 7.47 |
Acutaas Chemicals Cash Flow Screener - Liquidity Fundamentals
Screen ACUTAAS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹292, and net cash flow was an inflow of ₹30.
Over the same period, investing activities used ₹266 and financing activities provided ₹4.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 292 | 118 | 125 | 66 | -12 | 28 | 27 | 15 | 9 | 29 |
| Investing Activities | -266 | -224 | -365 | -33 | -121 | -101 | -24 | -21 | -25 | -19 |
Financing and Net Cash | ||||||||||
| Financing Activities | 4 | 261 | 239 | -12 | 140 | 72 | 0 | 6 | 15 | -7 |
| Net Cash Flow | 30 | 156 | -1 | 20 | 8 | -1 | 3 | 0 | -2 | 3 |
Acutaas Chemicals Shareholding Pattern Screener
See Acutaas Chemicals shareholding pattern with promoter, FII, and DII holdings. Check Acutaas Chemicals promoter holding and ownership changes for ACUTAAS on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Sept, promoters held 32.66%, foreign institutions 22.62%, domestic institutions 19.40% and the public 21.15%, spread across 147,026 shareholders.
The shareholder count was 147,026 in 2026-Sept, compared with 125,569 in 2026-Jun.
| Item | 2026-Sept | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 32.66% | 32.66% | 32.66% | 32.66% | 32.66% | 32.66% | 35.96% | 35.96% |
Institutional Investors | ||||||||
| FII Holding | 22.62% | 21.61% | 19.48% | 16.67% | 16.85% | 16.94% | 16.48% | 15.52% |
| DII Holding | 19.40% | 19.56% | 19.60% | 21.70% | 22.59% | 22.38% | 18.31% | 20.24% |
Government, Public and Others | ||||||||
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public Holding | 21.15% | 21.72% | 23.21% | 23.53% | 22.79% | 23.27% | 24.19% | 23.56% |
| Other Holding | 4.16% | 4.44% | 5.03% | 5.43% | 5.10% | 4.74% | 5.05% | 4.71% |
| Shareholder Count | 147,026 | 125,569 | 112,939 | 110,363 | 108,664 | 119,890 | 114,060 | 95,756 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Acutaas Chemicals. Acutaas Chemicals dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹2.50 per unit for 2026-March, a yield of 0.06%, compared with ₹1.50 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹2.50, ₹1.50 and ₹3.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹2.50 | 0.06% |
| 2025-March | ₹1.50 | 0.06% |
| 2024-March | ₹3.00 | 0.25% |
| 2023-March | ₹3.00 | 0.55% |
| 2022-March | ₹3.00 | 0.67% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Acutaas Chemicals Stock Index Membership - Nifty & Sensex
See which indices include Acutaas Chemicals stock. Check ACUTAAS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 5 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250.
Complete Index List
Acutaas Chemicals Market Events Screener - Corporate Actions
Get Acutaas Chemicals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Acutaas Chemicals stock events that may affect ACUTAAS share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 27, 2026, with a record date of October 27, 2026.
It is followed by Annual General Meeting dated September 24, 2026 and Dividend dated September 17, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-10-27 | 2026-10-27 | Quarterly Result Announcement | NA | 6.20% |
| 2026-09-24 | 2026-09-24 | Annual General Meeting | NA | 3.04% |
| 2026-09-17 | 2026-09-17 | Dividend | ₹ 2.50 /share | 33.69% |
| 2026-07-24 | 2026-07-24 | Quarterly Result Announcement | NA | -4.40% |
| 2026-04-30 | 2026-04-30 | Quarterly Result Announcement | NA | 4.41% |
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | 6.40% |
| 2025-10-17 | 2025-10-17 | Quarterly Result Announcement | NA | 9.21% |
| 2025-09-25 | 2025-09-25 | Annual General Meeting | NA | 2.54% |
| 2025-09-18 | 2025-09-18 | Dividend | ₹ 1.50 /share | 30.23% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | -1.68% |
| 2025-05-10 | 2025-05-10 | Extraordinary General Meeting | NA | -1.28% |
| 2025-05-02 | 2025-05-02 | Quarterly Result Announcement | NA | 2.71% |
| 2025-04-25 | 2025-04-25 | Split | 5:10 | -1.69% |
| 2025-04-16 | 2025-04-16 | Change Of Name | NA | 0.00% |
| 2025-01-28 | 2025-01-28 | Quarterly Result Announcement | NA | -3.43% |
Acutaas Chemicals Competitors Screener - Peer Stocks Comparison
Screen ACUTAAS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 448,676 | 40.80 | 61,674 | 12.69% | 11,565 | 60.46 |
| Divis Laboratories | 295,997 | 87.70 | 11,067 | 13.95% | 2,568 | 68.76 |
| Torrent Pharmaceuticals | 177,586 | 85.00 | 13,886 | 20.34% | 2,138 | 47.23 |
| Laurus Labs | 126,325 | 89.90 | 6,868 | 22.01% | 890 | 57.04 |
| Zydus Life Science | 120,119 | 27.60 | 27,658 | 17.64% | 5,026 | 55.91 |
| Dr Reddys Laboratories | 115,854 | 41.80 | 35,059 | 3.90% | 4,158 | 71.26 |
| Cipla | 112,131 | 39.50 | 29,045 | 2.24% | 3,870 | 53.06 |
| Mankind Pharma | 107,805 | 47.90 | 14,636 | 14.85% | 1,938 | 61.37 |
| Aurobindo Pharma | 103,229 | 25.80 | 34,145 | 5.56% | 3,503 | 60.39 |
| Lupin | 89,172 | 17.30 | 29,039 | 26.75% | 5,356 | 39.39 |
Acutaas Chemicals Company Announcements - News & Reports Screener
Screen ACUTAAS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 10, 2026.
The next most recent announcements are dated November 10, 2026 and November 2, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-11-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-11-10 | Annual Sustainability Report For The Financial Year 2025-26 | - |
| 2026-11-02 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-11-02 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-10-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-10-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-10-27 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-10-27 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-10-27 | Unaudited Standalone And Consolidated Financial Results For Second Quarter And Half Year Ended September 30 2026 | - |
| 2026-10-27 | Board Meeting Outcome for Outcome Of Board Meeting Held On October 27 2026 | - |
| 2026-10-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-10-22 | Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended September 30 2026 Scheduled On October 27 2026. | - |
| 2026-10-17 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-10-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-09-26 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-24 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-09-24 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-22 | Closure of Trading Window | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹3,991.30, within a 52-week range of ₹1,602.50 to ₹4,039.10. The P/E ratio is 73.60 and the P/B ratio is 17.38, with earnings per unit of ₹43.51. Market capitalisation stands at ₹32,280.96 Cr and the dividend yield is 0.06%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.